This program has been designed to help foster the creation of new, venture-attractive life sciences companies and development of exceptional corporate partnering opportunities in the Southeast. The application period is closed. Check back soon to see who the semi-finalists are!
read moreEnvoy Therapeutics, Inc., a drug discovery company, today announced that it has been awarded a second grant from The Michael J. Fox Foundation (MJFF). The additional funding will enable the continued development of compounds that selectively act on the motor circuitry that is compromised in Parkinson’s disease (PD) via modulation of a receptor target identified by Envoy.
read moreOctober 31 – November 1, 2012
The Breakers Resort
Palm Beach, Florida
Click on the image above for more information about the 2012 Investor Forum. Click here to apply to present! Deadline is June 29, 2012.
read more
Follow Us!